Yukiya Narita Selected Research

Yukiya Narita Research Topics

Disease

25	Stomach Neoplasms (Stomach Cancer) 10/2023 - 08/2014
20	Neoplasms (Cancer) 10/2023 - 04/2015
16	Colorectal Neoplasms (Colorectal Cancer) 11/2023 - 02/2014
5	Adenocarcinoma 06/2023 - 01/2017
4	Disease Progression 01/2021 - 08/2017
4	Neoplasm Metastasis (Metastasis) 01/2021 - 12/2017
3	Neutropenia 11/2023 - 01/2017
3	Esophageal Squamous Cell Carcinoma 01/2023 - 08/2015
3	Esophageal Neoplasms (Esophageal Cancer) 01/2020 - 08/2015
2	Febrile Neutropenia 11/2023 - 01/2017
2	Hypertension (High Blood Pressure) 10/2022 - 01/2017
2	Ascites 01/2021 - 09/2017
2	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 11/2020 - 01/2019
2	Mucositis 11/2020 - 08/2015
2	Diarrhea 11/2020 - 08/2015
2	Sarcopenia 10/2018 - 06/2017
2	Disseminated Intravascular Coagulation 09/2017 - 01/2017
2	Nausea 01/2017 - 09/2016
1	Squamous Cell Carcinoma of Head and Neck 03/2024
1	Nasopharyngeal Carcinoma 03/2024
1	Cachexia 10/2023
1	Colonic Neoplasms (Colon Cancer) 01/2023
1	Rectal Neoplasms (Rectal Cancer) 01/2023
1	Cholangitis 10/2022
1	Hyperlipidemias (Hyperlipidemia) 10/2022
1	Obstructive Jaundice (Cholestatic Jaundice) 10/2022
1	Microsatellite Instability 01/2021
1	Second Primary Neoplasms (Neoplasms, Second) 01/2020
1	Chronic Disease (Chronic Diseases) 01/2018
1	Hemangiosarcoma (Angiosarcoma) 09/2017
1	Brain Diseases (Brain Disorder) 06/2017
1	Thrombocytopenia (Thrombopenia) 01/2017
1	Leukopenia 01/2017
1	Multiple Endocrine Neoplasia Type 2a (MEN 2) 01/2017
1	Anemia 01/2017
1	Hand-Foot Syndrome 01/2017
1	Vomiting 09/2016
1	Peripheral Nervous System Diseases (PNS Diseases) 04/2015

Drug/Important Bio-Agent (IBA)

9	Bevacizumab (Avastin)FDA Link 11/2023 - 02/2014
8	Fluorouracil (Carac)FDA LinkGeneric 03/2024 - 04/2015
8	NivolumabIBA 10/2023 - 11/2018
7	Immune Checkpoint InhibitorsIBA 04/2023 - 01/2017
6	Cisplatin (Platino)FDA LinkGeneric 03/2024 - 08/2015
6	Irinotecan (Camptosar)FDA LinkGeneric 11/2023 - 09/2017
6	Oxaliplatin (Eloxatin)FDA LinkGeneric 11/2023 - 02/2014
6	Leucovorin (Folinic Acid)FDA Link 03/2023 - 04/2015
5	trifluridine tipiracil drug combinationIBA 11/2023 - 01/2017
4	taxaneIBA 07/2021 - 09/2017
3	Cetuximab (Erbitux)FDA Link 03/2024 - 03/2016
3	PlatinumIBA 01/2023 - 01/2017
3	RamucirumabIBA 07/2021 - 01/2019
3	Cytotoxins (Cytolysins)IBA 09/2020 - 08/2017
3	Trastuzumab (Herceptin)FDA Link 12/2018 - 08/2017
2	pembrolizumabIBA 03/2024 - 12/2021
2	Taxoids (Taxanes)IBA 06/2023 - 11/2018
2	Growth Factor ReceptorsIBA 01/2023 - 03/2016
2	ErbB Receptors (EGF Receptor)IBA 04/2021 - 01/2017
2	AntibodiesIBA 11/2018 - 01/2017
2	Biomarkers (Surrogate Marker)IBA 02/2018 - 01/2017
2	human ERBB2 proteinIBA 02/2018 - 08/2017
2	Dacarbazine (DIC)FDA LinkGeneric 09/2017 - 01/2017
2	Docetaxel (Taxotere)FDA Link 09/2017 - 08/2015
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2017 - 01/2017
2	regorafenibIBA 01/2017 - 01/2017
1	B7-H1 AntigenIBA 03/2024
1	Gemcitabine FDA Link 03/2024
1	Niacin (Nicotinic Acid)FDA LinkGeneric 10/2023
1	CarbonIBA 10/2023
1	Vitamin B 6IBA 10/2023
1	EnzymesIBA 10/2023
1	Proteins (Proteins, Gene)FDA Link 10/2023
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 10/2023
1	Vitamin B Complex (B Vitamins)IBA 10/2023
1	Monoclonal AntibodiesIBA 01/2023
1	Paclitaxel (Taxol)FDA LinkGeneric 09/2020
1	130-nm albumin-bound paclitaxelIBA 09/2017
1	Alanine Transaminase (SGPT)IBA 01/2017
1	BilirubinIBA 01/2017
1	Dexamethasone (Maxidex)FDA LinkGeneric 09/2016
1	Palonosetron (Aloxi)FDA Link 09/2016
1	Olanzapine (Zyprexa)FDA Link 09/2016
1	Panitumumab (Vectibix)FDA Link 03/2016
1	S-1 plus cisplatinIBA 08/2014
1	CarbohydratesIBA 02/2014
1	AntigensIBA 02/2014

Therapy/Procedure

30	Drug Therapy (Chemotherapy) 03/2024 - 02/2014
20	Therapeutics 03/2024 - 04/2015
5	Immunotherapy 04/2023 - 01/2017
2	Combination Drug Therapy (Combination Chemotherapy) 07/2021 - 08/2014
2	Drug Tapering 06/2017 - 08/2015
2	Neoadjuvant Therapy 10/2016 - 08/2015
2	Adjuvant Chemotherapy 08/2015 - 04/2015
1	Length of Stay 10/2022
1	Palliative Care (Palliative Therapy) 01/2021
1	Molecular Targeted Therapy 03/2017
1	Chemoradiotherapy 10/2016